Super-paramagnetic iron oxide nanoparticles for use in extrapulmonary tuberculosis diagnosis

Clinical Microbiology and Infection

Volumn 18, Issue 6, 2012, Pages

  Lee, C N ^a   Wang, Y M ^b   Lai, W F T ^c,e,g   Chen, T J ^b   Yu, M C ^d   Fang, C L ^c   Yu, F L ^d   Tsai, Y H ^e   Chang, W H S ^f   Zuo, C S ^g   Renshaw, P F ^g  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^g MCLEAN HOSPITAL   (United States)

Author keywords

Diagnosis; Extrapulmonary; Magnetic resonance imaging; Mycobaterium tuberculosis; Nanoparticle

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTRAST ENHANCEMENT; EXTRAPULMONARY TUBERCULOSIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

BACILLI (CLASS); MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84862785589     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03809.x     Document Type: Article

References (43)

1. Lauzardo M, Ashkin D. Phthisiology at the dawn of the new century: a review of tuberculosis and the prospects for its elimination. Chest 2000; 17: 1455-1473.
2. World Health Organization. Global tuberculosis control, surveillance, planning, financing. Geneva, Switzerland: World Health Organization. WHO Report. 2007.
3. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991; 324: 289-294.
4. Alvarez S, McCabe WR. Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine (Baltimore) 1984; 63: 25-55.
5. Ozbay B, Uzun K. Extrapulmonary tuberculosis in high prevalence of tuberculosis and low prevalence of HIV. Clin Chest Med 2002; 23: 351-354.
6. Ebdrup L, Storgaard M, Jensen-Fangel S, Obel N. Ten years of extrapulmonary tuberculosis in a Danish university clinic. Scand J Infect Dis 2003; 35: 244-246.
7. García-Elorriaga G, Gracida-Osorno C, Carrillo-Montes G, Gonzalez-Bonilla C. Clinical usefulness of the nested polymerase chain reaction in the diagnosis of extrapulmonary tuberculosis. Salud Pública de México 2009; 51: 240-245.
8. Steingart KR, Henry M, Laal S et al. A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Postgrad Med J 2007; 83: 705-712.
9. Liao CH, Chou CH, Lai CC et al. Diagnostic performance of an enzyme-linked immunospot assay for interferon-g in extrapulmonary tuberculosis varies between different sites of disease. J Infect 2009; 59: 402-408.
10. Kim SH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis. Arch Intern Med 2007; 167: 2255-2259.
11. Kim SH, Song KH, Choi SJ et al. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med 2009; 122: 189-195.
12. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
13. Koashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M. Clinical utility of a T cell-based assay in the diagnosis of extrapulmonary tuberculosis. Respirology 2009; 14: 276-281.
14. Paluch-Oleś J, Magrys A, Kot E, Koziol-Montewka M. Rapid identification of tuberculosis epididymo-orchitis by INNO-LiPA Rif TB and QuantiFERON-TB Gold In Tube tests: case report. Diagn Microbiol Infect Dis 2010; 66: 314-317.
15. Kaneko K, Onodera O, Miyatake T, Tsuji S. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction (PCR). Neurology 1990; 40: 1617-1618.
16. Bhigjee AI, Padayachee R, Paruk H, Hallwirth-Pillay KD, Marais S, Connoly C. Diagnosis of tuberculous meningitis: clinical and laboratory parameters. Int J Infect Dis 2007; 11: 348-354.
17. Barnes P. Rapid diagnostic test of tuberculosis: progress but no gold standard. Am J Respir Crit Care Med 1997; 155: 1497-1498.
18. Kumar P, Nath K, Rath B et al. Visual format for detection of Mycobacterium tuberculosis and M. bovis in clinical samples using molecular beacons. J Mol Diagn 2009; 11: 430-438.
19. Miyawaki A, Sawano A, Kogure T. Lighting up cells: labelling proteins with fluorophores. Nat Cell Biol 2003; September (suppl): S1-S7.
20. Weissleder R, Mahmood U. Molecular imaging. Radiology 1996; 219: 316-333.
21. Schrock E, du Manoir S, Veldman T. Multicolor spectral karyotyping of human chromosomes. Science 1996; 273: 494-497.
22. Jaiswal JK, Simon SM. Potentials and pitfalls of fluorescent quantum dots for biological imaging. Trends Cell Biol 2004; 14: 497-504.
23. Lai WF, Chang CH, Tang Y, Bronson R, Tung CH. Early diagnosis of osteoarthritis using cathepsin B sensitive near-infrared fluorescent probes. Osteoarthritis Cartilage 2004; 12: 239-244.
24. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005; 16: 63-72.
25. Michalet X, Pinaud FF, Bentolila LA et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005; 307: 538-544.
26. Voura EB, Jaiswal JK, Mattoussi H, Simon SM. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med 2004; 10: 993-998.
27. Howarth M, Takao K, Hayashi Y, Ting AY. Targeting quantum dots to surface proteins in living cells with biotin ligase. Proc Natl Acad Sci U S A 2005; 102: 7583-7588.
28. Stroh M, Zimmer JP, Duda DG et al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med 2005; 11: 678-682.
29. Colton HM, Falls JG, Ni H et al. Visualization and quantitation of peroxisomes using fluorescent nanocrystals: treatment of rats and monkeys with fibrates and detection in the liver. Toxicol Sci 2004; 80: 183-192.
30. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995-4021.
31. Talelli M, Rijcken CJ, Lammers T et al. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir 2009; 25: 2060-2067.
32. Cho W, Cho M, Kim SR et al. Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging. Toxicol Appl Pharmacol 2009; 239: 106-115.
33. Mahmoudi M, Simchi A, Milani AS, Stroeve P. Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci 2009; 336: 510-518.
34. Paul KG, Frigo TB, Groman JY, Groman EV. Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. Bioconjug Chem 2004; 15: 194-401.
35. Chen TJ, Cheng TH, Chen CY. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI. J Biol Inorg Chem 2009; 14: 253-260.
36. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175: 494-498.
37. Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
38. Angra P, Ridderhof J, Smithwick R. Comparison of two different strengths of carbol fuchsin in Ziehl-Neelsen staining for detecting acid-fast bacilli. J Clin Microbiol 2003; 41: 3459.
39. Woods A, Ellis R. Pigments, minerals, and other tissue deposits in Laboratory Histopathology- A Complete Reference, 1st edn. New York, NY: Churchill Livingstone, 1994; 8-11.
40. Wang J, Wakeham J, Harkness R, Xing Z. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest 1999; 103: 1023-1029.
41. Lee H, Yoon T, Weissleder R. Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-filter system. Angew Chem Int Ed 2009; 48: 5657-5660.
42. Nishie A, Yoshimitsu K, Nakayama T et al. In vitro imaging of human monocytic cellular activity using superparamagnetic iron oxide. Comput Med Imaging Graph 2007; 31: 638-642.
43. von Zur Muhlen C, von Elverfeldt D, Bassler N et al. Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis 2007; 193: 102-111.